DIA 2013 49th Annual Meeting
Click here to go to the previous page
Innovation and Evolution Within the Medical Science Liaison Role
Track : Track 06: Medical Communication, Medical Writing and Medical Science Liaison
Program Code: 208
Date: Tuesday, June 25, 2013
Time: 8:00 AM to 9:30 AM  EST
Location: 204AB
CHAIR :
 J. Lynn Bass, PharmD,RPh (SCHNON), Director, Medical Scientists, Jazz Pharmaceuticals, United States
SPEAKER (S):
Jane W Springer, BSN,RN (SPKNON), Principal Specialist, Medical Relations and Information, Amylin Pharmaceuticals, LLC, A Subsidiary of Bristol-Myers Squibb, United States
 Robin L. Winter-Sperry, MD (SPKNON), President and CEO, Scientific Advantage LLC, United States
Description
The pharmaceutical industry is composed of diverse constituents who, as a whole, result in a unique, overall industry composite. Since the inaugural team of Medical Science Liaisons (MSL) was deployed, the role and function of the individual MSL has evolved and pivoted in numerous directions. Modern day MSLs continue to evolve and represent the crucial link between the academic and investigator community with the pharmaceutical manufacturer. In this symposium, we will explore how an experienced MSL continues to develop professionally; the evolution, innovation, and challenges of the MSL's use of technology in their roles; and the future role of the MSL in educational activities.